Simple blood test may predict heart pump surgery risks
NCT ID NCT07497308
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for adults with advanced heart failure who are getting a mechanical heart pump (LVAD). Researchers want to see if a substance in the blood called GDF-15 can help predict early complications or death after surgery. The goal is to better identify high-risk patients before the operation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Akdeniz University, Faculty of Medicine, Department of Anesthesiology and Reanimation
RECRUITINGAntalya, Please Select:, 07050, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••